Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world studyDong Zhao, Kangsheng Gu, Xiaofei Cheng et al.|Frontiers in Immunology|2025Cited by 2